skip to content

Cambridge Institute for Medical Research


The ALBORADA Drug Discovery Institute (ADDI) at Cambridge bridges the gap between the deep disease understanding of academia and the drug development capabilities within the pharmaceutical/biotechnology industry and clinical centres of excellence. The ADDI is part of a wider Drug Discovery Alliance, funded by the charity Alzheimer’s Research UK and launched in 2014. The ADDI works alongside Institutes at the University of Oxford and University College London to create one of the largest coordinated efforts to drive academic drug discovery into neurodegenerative diseases. 

The ADDI enjoys close proxmity, administrative and research links to CIMR.

Link for more information about the ADDI.